Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neutrophil-derived itaconate facilitates tiered pulmonary inflammation via Kdm5b-associated epigenetic remodeling in alveolar macrophages.

Cell reports·2026
Same author

Dysregulation of helper, regulatory, and follicular CD4<sup>+</sup> T cells in primary antiphospholipid syndrome: Immunopathology and implications for targeted immunomodulatory therapy.

Autoimmunity reviews·2026
Same author

Comment on: Loss of antiphospholipid antibody positivity decreases the risk of recurrent thrombosis in thrombotic antiphospholipid syndrome: reply.

Rheumatology (Oxford, England)·2026
Same author

Loss of antiphospholipid antibody positivity decreases the risk of recurrent thrombosis in thrombotic antiphospholipid syndrome.

Rheumatology (Oxford, England)·2025
Same author

Addressing unmet needs in pregnancy and family planning of people living with rare and low-prevalence diseases: results of the "ERN transversal working group on pregnancy and family planning" survey.

Reproductive health·2025
Same author

Classification of Trypanosoma brucei mammalian life cycle stages using Deep Learning Algorithms.

PLoS neglected tropical diseases·2025

Related Experiment Video

Updated: Mar 28, 2026

Author Spotlight: Isolation and Culture of Primary Synovial Macrophages and Fibroblasts from Murine Arthritis Tissue
09:18

Author Spotlight: Isolation and Culture of Primary Synovial Macrophages and Fibroblasts from Murine Arthritis Tissue

Published on: February 24, 2023

10.8K

Decrease of CD68 Synovial Macrophages in Celastrol Treated Arthritic Rats.

Rita Cascão1, Bruno Vidal1, Inês P Lopes1

  • 1Instituto de Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal.

Plos One
|December 15, 2015
PubMed
Summary
This summary is machine-generated.

Celastrol effectively reduced inflammation and halted joint destruction in a rat model of rheumatoid arthritis (RA). This compound shows promise as a safe and cost-effective treatment for arthritis, targeting key inflammatory markers.

More Related Videos

Author Spotlight: Understanding the Mechanism of Tuina Manipulation in Rats
05:50

Author Spotlight: Understanding the Mechanism of Tuina Manipulation in Rats

Published on: June 30, 2023

3.6K
Flow Cytometry Analysis of Immune Cell Subsets within the Murine Spleen, Bone Marrow, Lymph Nodes and Synovial Tissue in an Osteoarthritis Model
12:23

Flow Cytometry Analysis of Immune Cell Subsets within the Murine Spleen, Bone Marrow, Lymph Nodes and Synovial Tissue in an Osteoarthritis Model

Published on: April 24, 2020

21.4K

Related Experiment Videos

Last Updated: Mar 28, 2026

Author Spotlight: Isolation and Culture of Primary Synovial Macrophages and Fibroblasts from Murine Arthritis Tissue
09:18

Author Spotlight: Isolation and Culture of Primary Synovial Macrophages and Fibroblasts from Murine Arthritis Tissue

Published on: February 24, 2023

10.8K
Author Spotlight: Understanding the Mechanism of Tuina Manipulation in Rats
05:50

Author Spotlight: Understanding the Mechanism of Tuina Manipulation in Rats

Published on: June 30, 2023

3.6K
Flow Cytometry Analysis of Immune Cell Subsets within the Murine Spleen, Bone Marrow, Lymph Nodes and Synovial Tissue in an Osteoarthritis Model
12:23

Flow Cytometry Analysis of Immune Cell Subsets within the Murine Spleen, Bone Marrow, Lymph Nodes and Synovial Tissue in an Osteoarthritis Model

Published on: April 24, 2020

21.4K

Area of Science:

  • Immunology
  • Pharmacology
  • Rheumatology

Background:

  • Rheumatoid arthritis (RA) is a chronic inflammatory disease causing joint damage, with current treatments offering limited efficacy and significant side effects.
  • Existing RA therapies achieve remission in only about 30% of patients and are often costly.
  • There is a critical need for novel arthritis treatments with improved safety profiles and lower production costs.

Purpose of the Study:

  • To evaluate the therapeutic potential of celastrol in an adjuvant-induced rat model of arthritis (AIA).
  • To assess celastrol's impact on sublining CD68 macrophages, a key biomarker for RA treatment response.
  • To examine celastrol's effects on synovial cellularity and joint structure in arthritic rats.

Main Methods:

  • Celastrol was administered to AIA rats during both early and late stages of arthritis development.
  • Evaluated inflammatory scores, ankle perimeter, body weight, and performed histopathological and immunohistochemical analyses.
  • Assessed toxicological parameters, including blood parameters and serum proinflammatory cytokines.

Main Results:

  • Celastrol significantly reduced the number of sublining CD68 macrophages, a marker of therapeutic response.
  • Observed a decrease in overall synovial inflammatory cellularity and halted joint destruction.
  • Treatment with celastrol did not result in any observed side effects.

Conclusions:

  • Celastrol demonstrates significant anti-inflammatory and joint-protective effects in an experimental arthritis model.
  • The compound effectively targets key cellular players in RA pathogenesis, including CD68 macrophages.
  • Celastrol is validated as a promising candidate for the development of novel arthritis therapies.